Asgard Therapeutics
Description: Asgard Therapeutics pioneers direct cell reprogramming for cancer immunotherapy using its proprietary TrojanDC tech, spun off from Lund University.
Country: Sweden
Based in: Lund
Founded: 2018
Funding Stage: Seed
Tags: ['Biotechnology', 'Therapeutics', 'Cell Reprogramming']
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.
